News

All news

2020-03-06

ACCORD HEALTHCARE LAUNCH ARSENIC TRIOXIDE

Accord Healthcare is delighted to announce the launch of Arsenic Trioxide 1 mg/ml, which will be available in a pack size of 10 vials of 10 ml.

This medicine is indicated for induction of remission, and consolidation in adult patients with certain genetically-characterised types of acute promyelocytic leukaemia (APL), in combination with all-trans-retinoic acid (ATRA) or in relapsed/refractory APL where previous treatment included a retinoid and chemotherapy.

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC is available from the www.hpra.ie and the products section of this website. 

For further information please contact Accord in Cork on 021-461 9040.

 

Date of Preparation: December 2019. IE-01467

 

 

All news